GLP-1 Drugs Mounjaro, Zepbound Show Promise For 1 Billion With Sleep Apnea

GLP-1 Drugs Mounjaro, Zepbound Show Promise For 1 Billion With Sleep Apnea

Credit: iStock

Text

Updated Sep 11, 2026 | 07:04 PM IST

SummaryGLP-1 drugs may be appropriate for people with a BMI above 30 who are unable to tolerate CPAP or have obesity-related comorbidities, revealed the study. They are less likely to benefit people without obesity or those with primarily anatomical airway obstruction.

End of Article